US$ 22.42
when was semaglutide approved by fda Approves Oral as the First Oral GLP-1 Pill Oral Semaglutide Gets FDA Approval
Description
There are no large trials proving safety, but early data suggests milk transfer is low

(April 8, 2025) As glucagon-like peptide 1 (GLP-1) prescription medications commonly used for diabetes management and weight loss continue to increase in popularity, some...

Retatrutide is the new talk of the town
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
The first symptom of NAION is usually that one eye suddenly and painlessly goes blind as the optic nerve stops receiving enough blood
Een nieuwe studie, die onlangs is gepubliceerd in JAMA Network Open, suggereert dat GLP-1 (glucagon-like peptide-1) receptoragonisten, die momenteel goedgekeurd zijn voor de behandeling van diabetes en obesitas, mogelijk een bijkomend voordeel hebben: ze kunnen het risico op bepaalde met obesitas geassocieerde kankers (obesity associated cancers, OACs) verminderen